Cargando…

Normalized T1 Magnetic Resonance Imaging for Assessment of Regional Lung Function in Adult Cystic Fibrosis Patients - A Cross-Sectional Study

BACKGROUND: Cystic fibrosis (CF) patients would benefit from a safe and effective tool to detect early-stage, regional lung disease to allow for early intervention. Magnetic Resonance Imaging (MRI) is a safe, non-invasive procedure capable of providing quantitative assessments of disease without ion...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dasenbrook, Elliott C., Lu, Lan, Donnola, Shannon, Weaver, David E., Gulani, Vikas, Jakob, Peter M., Konstan, Michael W., Flask, Chris A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3783461/ https://www.ncbi.nlm.nih.gov/pubmed/24086277 http://dx.doi.org/10.1371/journal.pone.0073286

Ejemplares similares

Lumacaftor/ivacaftor therapy is associated with reduced hepatic steatosis in cystic fibrosis patients
por: Kutney, Katherine, et al.
Publicado: (2019)

Eradication strategy for persistent methicillin-resistant Staphylococcus aureus infection in individuals with cystic fibrosis—the PMEP trial: study protocol for a randomized controlled trial
por: Jennings, Mark T, et al.
Publicado: (2014)

Dual Contrast - Magnetic Resonance Fingerprinting (DC-MRF): A Platform for Simultaneous Quantification of Multiple MRI Contrast Agents
por: Anderson, Christian E., et al.
Publicado: (2017)

Financial impacts of the COVID-19 pandemic on cystic fibrosis care: lessons for the future()
por: Sawicki, Gregory S., et al.
Publicado: (2021)

Managing Cystic Fibrosis related diabetes via telehealth during COVID-19 pandemic
por: Hasan, Sana, et al.
Publicado: (2021)

Molecular Imaging of Tumors Using a Quantitative T(1) Mapping Technique via Magnetic Resonance Imaging
por: Herrmann, Kelsey, et al.
Publicado: (2015)

Characterizing Lung Disease in Cystic Fibrosis with Magnetic Resonance Imaging and Airway Physiology
por: Theilmann, Rebecca J., et al.
Publicado: (2016)

Magnetic Resonance Fingerprinting
por: Ma, Dan, et al.
Publicado: (2013)

Feasibility of Magnetic Resonance Fingerprinting on Aging MRI Hardware
por: Eck, Brendan Lee, et al.
Publicado: (2021)

A System for Real-Time, Online Mixed-Reality Visualization of Cardiac Magnetic Resonance Images
por: Franson, Dominique, et al.
Publicado: (2021)

Cardiac involvement in cystic fibrosis evaluated using cardiopulmonary magnetic resonance
por: Lagan, Jakub, et al.
Publicado: (2022)

Chest magnetic resonance imaging in cystic fibrosis: technique and clinical benefits
por: Gräfe, Daniel, et al.
Publicado: (2022)

Improved Growth Patterns in Cystic Fibrosis Mice after Loss of Histone Deacetylase 6
por: Rymut, Sharon M., et al.
Publicado: (2017)

Evaluating assumptions of definition-based pulmonary exacerbation endpoints in cystic fibrosis clinical trials
por: VanDevanter, Donald R., et al.
Publicado: (2021)

Assessing time to pulmonary function benefit following antibiotic treatment of acute cystic fibrosis exacerbations
por: VanDevanter, Donald R, et al.
Publicado: (2010)

Healthcare resource utilization and costs among children with cystic fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Long-Term Impact of Ivacaftor on Healthcare Resource Utilization Among People with Cystic Fibrosis in the United States
por: Thorat, Teja, et al.
Publicado: (2021)

Simultaneous T(1) and T(2) Brain Relaxometry in Asymptomatic Volunteers Using Magnetic Resonance Fingerprinting
por: Badve, Chaitra, et al.
Publicado: (2015)

Dynamic Quantitative T1 Mapping in Orthotopic Brain Tumor Xenografts()
por: Herrmann, Kelsey, et al.
Publicado: (2016)

Secretin-stimulated ultrasound estimation of pancreatic secretion in cystic fibrosis validated by magnetic resonance imaging
por: Engjom, Trond, et al.
Publicado: (2017)

Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: Current practices and research priorities
por: Lanzkron, Sophie, et al.
Publicado: (2019)

Functional lung MRI for regional monitoring of patients with cystic fibrosis
por: Kaireit, Till F., et al.
Publicado: (2017)

Modeling long-term health outcomes of patients with cystic fibrosis homozygous for F508del-CFTR treated with lumacaftor/ivacaftor
por: Rubin, Jaime L., et al.
Publicado: (2019)

Foretelling Early Lung Disease Progression in Cystic Fibrosis: The Combined Benefits of Magnetic Resonance Imaging and Newborn Screening
por: Goralski, Jennifer L.
Publicado: (2021)

Magnetic resonance imaging detects onset and association with lung disease severity of bronchial artery dilatation in cystic fibrosis
por: Leutz-Schmidt, Patricia, et al.
Publicado: (2023)

Data from the US and UK cystic fibrosis registries support disease modification by CFTR modulation with ivacaftor
por: Bessonova, Leona, et al.
Publicado: (2018)

Landmark‐guided region‐based spatial normalization for functional magnetic resonance imaging
por: He, Hengda, et al.
Publicado: (2022)

Regional brain tissue changes in patients with cystic fibrosis
por: Roy, Bhaswati, et al.
Publicado: (2021)

Polarized Signaling via Purinoceptors in Normal and Cystic Fibrosis Airway Epithelia
por: Paradiso, Anthony M., et al.
Publicado: (2001)

Macrorheology of cystic fibrosis, chronic obstructive pulmonary disease & normal sputum
por: Serisier, David J, et al.
Publicado: (2009)

Early Effects of Elexacaftor-Tezacaftor-Ivacaftor Therapy on Magnetic Resonance Imaging in Patients with Cystic Fibrosis and Advanced Lung Disease
por: Macconi, Letizia, et al.
Publicado: (2022)

Long-term effects of lumacaftor/ivacaftor on paranasal sinus abnormalities in children with cystic fibrosis detected with magnetic resonance imaging
por: Wucherpfennig, Lena, et al.
Publicado: (2023)

Book Review: LeukaemiaGenetic testingCystic fibrosisThe rhesus factor and disease prevention
por: Weaver, Lawrence
Publicado: (2006)

Cystic Fibrosis
por: Gibson, Lewis E.
Publicado: (1969)

Cystic Fibrosis
por: Dodge, J A
Publicado: (1997)

Normal reference values for aerobic fitness in cystic fibrosis: a scoping review
por: Tomlinson, Owen W, et al.
Publicado: (2022)

CYSTIC FIBROSIS OF THE PANCREAS : A STUDY IN CELL CULTURE
por: Danes, B. Shannon, et al.
Publicado: (1969)

OYSTER CILIARY INHIBITION BY CYSTIC FIBROSIS CULTURE MEDIUM
por: Danes, B. Shannon, et al.
Publicado: (1972)

Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study
por: Nowak, Jan K., et al.
Publicado: (2017)

Rate of Lung Function Decline in People with Cystic Fibrosis Having a Residual Function Gene Mutation
por: Sawicki, Gregory S., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_kt5pt5qi69ueugrnpmavjlinrp